David Coutant is currently the Executive Director at Eli Lilly and Company, having begun their tenure in 2025 following a series of advancing roles, including Senior Director and Principal Research Scientist. They completed an 18-month sabbatical in the US Regulatory Affairs division, focusing on large molecule diabetic treatments, during which they achieved Regulatory Affairs Certification and published several articles, including one that won the DIA Donald E. Franke award. David earned a PhD in Chemistry from the University of Michigan and is pursuing a Bachelor of Science in Chemistry from Miami University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices